Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Gadoteric acid 279.3mg/mL|
|Dosage Form:||Solution for injection|
|New Zealand Sponsor:||GE Healthcare Limited|
|Manufacturer:||GE Healthcare AS, Oslo, Norway|
Dated this 10th day of August 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).